吉林敖东：控股子公司获药品注册证书

Core Viewpoint - Jilin Aodong announced that its subsidiary Yanji Pharmaceutical has received the "Drug Registration Certificate" for "Sulfate Terbutaline Nebulized Inhalation Solution" from the National Medical Products Administration, which is used to relieve bronchial asthma, chronic bronchitis, emphysema, and other lung diseases associated with bronchospasm [1] Group 1 - The approval of the drug registration certificate enhances the company's product structure [1] - The new product enriches the variety of the company's offerings [1] - This development strengthens the company's core competitiveness [1]